Antibody-Drug Conjugates

Callio Therapeutics Names Zachary Hornby as CEO

San Diego, Seattle and Singapore, September 9, 2026 Callio Therapeutics has appointed Zachary “Zach” Hornby as Chief Executive Officer,...

By cGxPwire Editor
September 10, 2026

.VC

NovaGo Raises $30M to Advance Spinal Cord Therapy

Zurich, Switzerland, September 2, 2026 NovaGo Therapeutics, a Swiss clinical-stage biotechnology company developing antibody therapeutics for nerve growth and...

By cGxPwire Editor
September 4, 2026

Bio-Pharma

Styx and ZoeNCure Advance Next-Generation ADCs to Clinic

San Diego, California, USA, September 1, 2026 Styx Biotechnologies Inc., a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for...

By cGxPwire Editor
September 4, 2026

M&A

DualityBio and Genentech Partner on Next-Gen ADCs

SHANGHAI, CHINA, Aug 28, 2026 Duality Biotherapeutics, Inc. (DualityBio) has entered into a global collaboration and license agreement with...

By cGxPwire Editor
August 29, 2026

Bio-Pharma

Akeso Reports 2026 Growth, Advances Global Drug Pipeline

HONG KONG, Aug 27, 2026 Akeso, Inc. announced its 2026 interim results, reporting record commercial drug sales while advancing...

By cGxPwire Editor
August 28, 2026

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

.VC

Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth

NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...

By cGxPwire Editor
June 16, 2026

MedTech

Medtronic Expands Hugo Robotic Surgery System with New FDA Filings

GALWAY, Ireland, June 3, 2026 Medtronic has announced a series of major regulatory and clinical milestones aimed at significantly...

By cGxPwire Editor
June 3, 2026

Bio-Pharma

Lifordi Gains Major Investment to Advance ADC Autoimmune Therapy

Dateline Introduction Burlington, Massachusetts — November 18, 2025 — Lifordi Immunotherapeutics has announced a strategic investment from Sanofi Ventures,...